Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.6004/jnccn.2020.7643 http://scihub22266oqcxt.onion/10.6004/jnccn.2020.7643 33027755!8173586!33027755     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33027755&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Natl+Compr+Canc+Netw 2021 ; 19 (5): 505-512 Nephropedia Template TP {{tp|p=33027755|t=2021. Experience, Perceptions, and Recommendations Concerning COVID-19-Related Clinical Research Adjustments |pdf=|usr=}}{{33027755}} gab.com Text Experience, Perceptions, and Recommendations Concerning COVID-19-Related Clinical Research Adjustments JO: J Natl Compr Canc Netw http://www.kidney.de/pget.php?&tw=1&pmid=33027755 #FOAvip BACKGROUND: During the COVID-19 public health emergency, the FDA and NIH altered clinical trial requirements to protect participants and manage study conduct. Given their detailed knowledge of research protocols and regular contact with patients, clinicians, and sponsors, clinical research professionals offer important perspectives on these changes. METHODS: We developed and distributed an anonymous survey assessing COVID-19-related clinical trial adjustment experiences, perceptions, and recommendations to Clinical Research Office personnel at the Harold C. Simmons Comprehensive Cancer Center. Responses were compared using the Fisher exact test. RESULTS: A total of 94 of 109 contacted research personnel (87%) responded. Among these individuals, 58% had >5 years' professional experience in clinical research, and 56% had personal experience with a COVID-19-related change. Respondents perceived that these changes had a positive impact on patient safety; treatment efficacy; patient and staff experience; and communication with patients, investigators, and sponsors. More than 90% felt that positive changes should be continued after COVID-19. For remote consent, telehealth, therapy shipment, off-site diagnostics, and remote monitoring, individuals with personal experience with the specific change and individuals with >5 years' professional experience were numerically more likely to recommend continuing the adjustment, and these differences were significant for telehealth (P=.04) and therapy shipment (P=.02). CONCLUSIONS: Clinical research professionals perceive that COVID-19-related clinical trial adjustments positively impact multiple aspects of study conduct. Those with greatest experience-both specific to COVID-19-related changes and more generally-are more likely to recommend that these adjustments continue in the future. Twit Text FOAVip Experience, Perceptions, and Recommendations Concerning COVID-19-Related Clinical Research Adjustments ????J Natl Compr Canc Netw http://www.kidney.de/pget.php?&tw=1&pmid=33027755 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33027755 #FOAvip English Wikipedia <ref>{{Cite pmid|33027755}}</ref> Experience, Perceptions, and Recommendations Concerning COVID-19-Related Clinical Research Adjustments #MMPMID33027755 Gerber DE; Sheffield TY; Beg MS; Williams EL; Clark VL; Xie Y; Holbein MEB; Skinner CS; Lee SJC J Natl Compr Canc Netw 2021[May]; 19 (5): 505-512 PMID33027755show ga BACKGROUND: During the COVID-19 public health emergency, the FDA and NIH altered clinical trial requirements to protect participants and manage study conduct. Given their detailed knowledge of research protocols and regular contact with patients, clinicians, and sponsors, clinical research professionals offer important perspectives on these changes. METHODS: We developed and distributed an anonymous survey assessing COVID-19-related clinical trial adjustment experiences, perceptions, and recommendations to Clinical Research Office personnel at the Harold C. Simmons Comprehensive Cancer Center. Responses were compared using the Fisher exact test. RESULTS: A total of 94 of 109 contacted research personnel (87%) responded. Among these individuals, 58% had >5 years' professional experience in clinical research, and 56% had personal experience with a COVID-19-related change. Respondents perceived that these changes had a positive impact on patient safety; treatment efficacy; patient and staff experience; and communication with patients, investigators, and sponsors. More than 90% felt that positive changes should be continued after COVID-19. For remote consent, telehealth, therapy shipment, off-site diagnostics, and remote monitoring, individuals with personal experience with the specific change and individuals with >5 years' professional experience were numerically more likely to recommend continuing the adjustment, and these differences were significant for telehealth (P=.04) and therapy shipment (P=.02). CONCLUSIONS: Clinical research professionals perceive that COVID-19-related clinical trial adjustments positively impact multiple aspects of study conduct. Those with greatest experience-both specific to COVID-19-related changes and more generally-are more likely to recommend that these adjustments continue in the future. |*Interdisciplinary Communication[MESH] |Biomedical Research/*standards[MESH] |COVID-19/*prevention & control/virology[MESH] |Delivery of Health Care/*standards[MESH] |Humans[MESH] |Practice Guidelines as Topic/*standards[MESH] |SARS-CoV-2/*isolation & purification[MESH] |Surveys and Questionnaires[MESH]Experience, Perceptions, and Recommendations Concerning COVID-19-Relat(epmc).pdf DeepDyve Pubget Overpricing